HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Topiramate in the treatment of highly refractory patients with Dravet syndrome.

Abstract
The purpose of this study was to assess the effectiveness and tolerability of topiramate (TPM) as add-on therapy in children with Dravet syndrome and considered unsatisfactorily controlled using stiripentol. All the 36 patients having been treated with TPM in our centre in 2001 were retrospectively evaluated. Seventy percent of them still received stiripentol when TPM was introduced. The association of both drugs did not need any particular adaptation of dosages. The mean TPM follow-up was 13.3 months (4-25 months) and the mean optimal TPM dose was 3.2 mg/kg/d (0.6-9.2 mg/kg/d). Twenty eight children (78 %) showed more than 50 % reduction in the frequency of generalized tonic-clonic seizures and status epilepticus (SE), whereas 8 % had more than 50 % increase. Six patients (17 %) remained seizure-free for at least 4 months. The most frequently reported side-effects were gastrointestinal and behavioural disturbances. TPM had to be stopped in 17 % of patients, because of poor tolerability and/or lack of efficacy. Topiramate seems therefore to be helpful in Dravet syndrome, even in patients not satisfactorily controlled by stiripentol. Both drugs can be easily and safely associated.
AuthorsJ Kröll-Seger, P Portilla, O Dulac, C Chiron
JournalNeuropediatrics (Neuropediatrics) Vol. 37 Issue 6 Pg. 325-9 (Dec 2006) ISSN: 0174-304X [Print] Germany
PMID17357033 (Publication Type: Journal Article)
Chemical References
  • Anticonvulsants
  • Dioxolanes
  • Topiramate
  • Fructose
  • stiripentol
Topics
  • Anticonvulsants (administration & dosage, adverse effects)
  • Dioxolanes (administration & dosage, adverse effects)
  • Drug Therapy, Combination
  • Electroencephalography (drug effects)
  • Epilepsies, Myoclonic (diagnosis, drug therapy)
  • Epilepsy, Tonic-Clonic (diagnosis, drug therapy)
  • Female
  • Follow-Up Studies
  • Fructose (administration & dosage, adverse effects, analogs & derivatives)
  • Humans
  • Infant
  • Male
  • Retrospective Studies
  • Seizures, Febrile (diagnosis, drug therapy)
  • Status Epilepticus (diagnosis, drug therapy)
  • Topiramate
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: